Tetanus: Pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms

Toxins

Volumn 5, Issue 1, 2013, Pages 73-83

  Hassel, Bjørnar ^a,b  

^a NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Botulinum toxin; Clostridium tetani; Dysphagia; Lockjaw; Tetanospasmin; Tetanus; Trismus

Indexed keywords

BACLOFEN; BENZODIAZEPINE; BOTULINUM TOXIN; BOTULINUM TOXIN A; DANTROLENE; METRONIDAZOLE; PANCURONIUM; PENICILLIN DERIVATIVE; PIPECURONIUM; PROPOFOL; TETANUS ANTIBODY;

CLOSTRIDIUM TETANI; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; MUSCLE RIGIDITY; MUSCLE SPASM; PATHOPHYSIOLOGY; PATIENT SAFETY; REVIEW; SYMPTOMATOLOGY; TETANUS; TETANUS PROPHYLAXIS; TRISMUS;

ANIMALS; BOTULINUM TOXINS, TYPE A; HUMANS; MODELS, ANIMAL; NEUROMUSCULAR AGENTS; SPASM; TETANUS; TRISMUS;

EID: 84873730397     PISSN: 20726651     EISSN: None     Source Type: Journal    
DOI: 10.3390/toxins5010073     Document Type: Review

References (64)

1. Bleck, T.P. Clostridium tetani (Tetanus). In Principles and Practice of Infectious Diseases, 6th ed.; Mandell, G.L., Bennett, J.E., Dolin, R., Eds.; Elsevier: Amsterdam, The Netherlands, 2005; pp. 2817-2822.
2. Thwaites, C.L.; Farrar, J.J. Preventing and treating tetanus. BMJ 2003, 326, 117-118.
3. Blencowe, H.; Lawn, J.; Vandelaer, J.; Roper, M.; Cousens, S. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int. J. Epidemiol. 2010, 39, i102-i109.
4. Meyer, H.; Ransom, F. Researches on tetanus-Preliminary communication. Proc. Royal Soc. Lond. 1903, 72, 26-30.
5. Fishman, P.S.; Carrigan, D.R. Motoneuron uptake from the circulation of the binding fragment of tetanus toxin. Arch. Neurol. 1988, 45, 558-561.
6. Blum, F.C.; Chen, C.; Kroken, A.R.; Barbieri, J.T. Tetanus toxin and botulinum toxin A utilize unique mechanisms to enter neurons of the central nervous system. Infect. Immun. 2012, 80, 1662-1669.
7. Schiavo, G.; Matteoli, M.; Montecucco, C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 2000, 80, 717-766.
8. Mayo, J.; Berciano, J. Cephalic tetanus presenting with Bell's palsy. J. Neurol. Neurosurg. Psychiatry 1985, 48, 290.
9. Herrman, H.; Brækhus, A.; Aaserud, O.; Aukrust, P.; Stubhaug, A.; Hassel, B. Early treatment of tetanus-induced trismus with botulinum toxin A. Anesth. Analg. 2008, 106, 1591.
10. Schwab, M.E.; Thoenen, H. Electron microscopic evidence for a transsynaptic migration of tetanus toxin in spinal cord motoneurons: An autoradiographic and morphometric study. Brain Res. 1976, 105, 213-227.
11. González-Forero, D.; Morcuende, S.; Alvarez, F.J.; de la Cruz, R.R.; Pastor, A.M. Transynaptic effects of tetanus neurotoxin in the oculomotor system. Brain 2005, 128, 2175-2188.
12. Brooks, V.B.; Curtis, D.R.; Eccles, J.C. The action of tetanus toxin on the inhibition of motoneurones. J. Physiol. 1957, 135, 655-672.
13. Bergey, G.K.; Bigalke, H.; Nelson, P.G. Differential effects of tetanus toxin on inhibitory and excitatory synaptic transmission in mammalian spinal cord neurons in culture: A presynaptic locus of action for tetanus toxin. J. Neurophysiol. 1987, 57, 121-131.
14. Gonzalez-Forero, D.; de la Cruz, R.R.; Delgado-Garcia, J.M.; Alvarez, F.J.; Pastor, A.M. Functional alterations of cat abducens neurons after peripheral tetanus neurotoxin injection. J. Neurophysiol. 2003, 89, 1878-1890.
15. Shin, M.C.; Nonaka, K.; Wakita, M.; Yamaga, T.; Torii, Y.; Harakawa, T.; Ginnaga, A.; Ito, Y.; Akaike, N. Effects of tetanus toxin on spontaneous and evoked transmitter release at inhibitory and excitatory synapses in the rat SDCN neurons. Toxicon 2012, 59, 385-392.
16. González-Forero, D.; Pastor, A.M.; Delgado-García, J.M.; de la Cruz, R.R.; Alvarez, F.J. Synaptic structural modification following changes in activity induced by tetanus neurotoxin in cat abducens neurons. J. Comp. Neurol. 2004, 471, 201-218.
17. Weng, W.C.; Huang, W.Y.; Peng, T.I.; Chien, Y.Y.; Chang, K.H.; Ro, L.S.; Lyu, R.K.; Wu, C.L. Clinical characteristics of adult tetanus in a Taiwan medical center. J. Formos. Med. Assoc. 2011, 110, 705-710.
18. Amare, A.; Melkamu, Y; Mekonnen, D. Tetanus in adults: Clinical presentation, treatment and predictors of mortality in a tertiary hospital in Ethiopia. J. Neurol. Sci. 2012, 317, 62-65.
19. Meienberg, O.; Burgunder, J.M. Saccadic eye movement disorder in cephalic tetanus. Eur. Neurol. 1985, 24, 182-190.
20. Orwitz, J.I.; Galetta, S.L.; Teener, J.W. Bilateral trochlear nerve palsy and downbeat nystagmus in a patient with cephalic tetanus. Neurology 1997, 49, 894-895.
21. Kagoya, R.; Iwasaki, S.; Chihara, Y.; Ushio, M.; Tsuji, S.; Murofushi, T.; Yamasoba, T. Cephalic tetanus presenting as acute vertigo with bilateral vestibulopathy. Acta Otolaryngol. 2011, 131, 334-336.
22. Kerr, J.H.; Corbett, J.L.; Prys-Roberts, C.; Smith, A.C.; Spalding, J.M. Involvement of the sympathetic nervous system in tetanus. Studies on 82 cases. Lancet 1968, 2, 236-241.
23. Cook, T.M.; Protheroe, R.T.; Handel, J.M. Tetanus: A review of the literature. Br. J. Anaesth. 2001, 87, 477-487.
24. Freshwater-Turner, D.; Udy, A.; Lipman, J.; Deans, R.; Stuart, J.; Boots, R.; Hegde, R.; McWhinney, B.C. Autonomic dysfunction in tetanus-What lessons can be learnt with specific reference to α-2 agonists? Anaesthesia 2007, 62, 1066-1070.
25. Pomara, C.; Neri, M.; Riezzo, I.; Turillazzi, E.; Fineschi, V. Autonomic nervous system instability, tetanic necrosis of the heart and myocardial TNFα expression in a tetanus fatal case. Int. J. Cardiol. 2009, 136, e54-e57.
26. Meckler, R.L.; Baron, R.; McLachlan, E.M. Selective uptake of C-fragment of tetanus toxin by sympathetic preganglionic nerve terminals. Neuroscience 1990, 36, 823-829.
27. Burgess, J.A.; Wambaugh, G.W.; Koczarski, M.J. Report of case: Reviewing cephalic tetanus. J. Am. Dent. Assoc. 1992, 123, 67-70.
28. Larsson, M.; Persson, S.; Ottersen, O.P.; Broman, J. Quantitative analysis of immunogold labeling indicates low levels and non-vesicular localization of L-aspartate in rat primary afferent terminals. J. Comp. Neurol. 2001, 430, 147-159.
29. Anlar, B.; Yalaz, K.; Dizmen, R. Long-term prognosis after neonatal tetanus. Dev. Med. Child Neurol. 1989, 31, 76-80.
30. Barkmeier, D.T.; Loeb, J.A. An animal model to study the clinical significance of interictal spiking. Clin. EEG Neurosci. 2009, 40, 234-238.
31. Ganesh Kumar, A.V.; Kothari, V.M.; Krishnan, A.; Karnad, D.R. Benzathine penicillin, metronidazole and benzyl penicillin in the treatment of tetanus: A randomized, controlled trial. Ann. Trop. Med. Parasitol. 2004, 98, 59-63.
32. Campbell, J.I.; Lam, T.M.; Huynh, T.L.; To, S.D.; Tran, T.T.; Nguyen, V.M.; Le, T.S.; Nguyen, V.C.; Parry, C.; Farrar, J.J.; Tran, T.H.; Baker, S. Microbiologic characterization and antimicrobial susceptibility of Clostridium tetani isolated from wounds of patients with clinically diagnosed tetanus. Am. J. Trop. Med. Hyg. 2009, 80, 827-831.
33. Blake, P.A.; Feldman, R.A.; Buchanan, T.M.; Brooks, G.F.; Bennett, J.V. Serologic therapy of tetanus in the United States, 1965-1971. J. Am. Med. Assoc. 1976, 235, 42-44.
34. Kabura, L.; Ilibagiza, D.; Menten, J.; van den Ende, J. Intrathecal vs. intramuscular administration of human antitetanus immunoglobulin or equine tetanus antitoxin in the treatment of tetanus: A meta-analysis. Trop. Med. Int. Health 2006, 11, 1075-1081.
35. Okoromah, C.N.; Lesi, F.E. Diazepam for treating tetanus. Cochrane Database Syst. Rev. 2004, doi:10.1002/14651858.CD003954.pub2.
36. Santos, M.L.; Mota-Miranda, A.; Alves-Pereira, A.; Gomes, A.; Correia, J.; Marçal, N. Intrathecal baclofen for the treatment of tetanus. Clin. Infect. Dis. 2004, 38, 321-328.
37. Orko, R.; Rosenberg, P.H.; Himberg, J.J. Intravenous infusion of midazolam, propofol and vecuronium in a patient with severe tetanus. Acta Anaesthesiol. Scand. 1988, 32, 590-592.
38. Dutta, T.K.; Das, A.K.; Sethuraman, K.R.; Swaminathan, R.P. Neuroparalysis and ventilator support in severe tetanus. J. Indian Med. Assoc. 2006, 104, 63-66.
39. Del Castillo, J.; Engbaek, L. The nature of the neuromuscular block produced by magnesium. J. Physiol. 1954, 124, 370-384.
40. Lee, C.; Zhang, X.; Kwan, W.F. Electromyographic and mechanomyographic characteristics of neuromuscular block by magnesium sulphate in the pig. Br. J. Anaesth. 1996, 76, 278-283.
41. 2+ at developing mouse end-plates. Pflugers Arch. 2000, 440, 704-709.
42. Thwaites, C.L.; Yen, L.M.; Loan, H.T.; Thuy, T.T.; Thwaites, G.E.; Stepniewska, K.; Soni, N.; White, N.J.; Farrar, J.J. Magnesium sulphate for treatment of severe tetanus: A randomised controlled trial. Lancet 2006, 368, 1436-1443.
43. Thwaites, C.L.; Yen, L.M.; Cordon, S.M.; Thwaites, G.E.; Loan, H.T.; Thuy, T.T.; White, N.J.; Soni, N.; Macdonald, I.A.; Farrar, J.J. Effect of magnesium sulphate on urinary catecholamine excretion in severe tetanus. Anaesthesia 2008, 63, 719-725.
44. Aguilar Bernal, O.R.; Bender, M.A.; Lacy, M.E. Efficacy of dantrolene sodium in management of tetanus in children. J. R. Soc. Med. 1986, 79, 277-281.
45. Restivo, D.A.; Marchese-Ragona, R. Botulinum toxin treatment for oropharyngeal dysphagia due to tetanus. J. Neurol. 2006, 253, 388-389.
46. Sharma, A.; Malhotra, S.; Grover, S.; Jindal, S.K. Incidence, prevalence, risk factor and outcome of delirium in intensive care unit: A study from India. Gen. Hosp. Psychiatry 2012, 34, 639-646.
47. Lambo, J.; Khahro, Z.; Memon, M.; Lashari, M. Neonatal tetanus incidence in Dadu District, Pakistan, 1993-2003. Scand. J. Infect. Dis. 2011, 43, 175-180.
48. van den Berg, J.P.; Westerbeek, E.A.; Berbers, G.A.; van Gageldonk, P.G.; van der Klis, F.R.; van Elburg, R.M. Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants. Pediatr. Infect. Dis. J. 2010, 29, 801-805.
49. Andrade, L.A.; Brucki, S.M. Botulinum toxin A for trismus in cephalic tetanus. Arq. Neuropsiquiatr. 1994, 52, 410-413.
50. Gaber, T.A.; Mannemela, S. Botulinum toxin for muscle spasm after tetanus. J. R. Soc. Med. 2005, 98, 554.
51. García-García, A.; Gandara-Rey, J.M.; Crespo-Abelleira, A.; Jorge-Barreiro, J. Botulinum toxin A for treating muscular contractures in cephalic tetanus. Br. J. Oral Maxillofac. Surg. 2007 45, 573-575.
52. Hexsel, D.; Brum, C.; do Prado, D.Z.; Soirefmann, M.; Rotta, F.T.; Dalforno, T.; Rodrigues, T.C. Field effect of two commercial preparations of botulinum toxin type A: A prospective, double-blind, randomized clinical trial. J. Am. Acad. Dermatol. 2012, 67, 226-232.
53. Antonucci, F.; Rossi, C.; Gianfranceschi, L.; Rossetto, O.; Caleo, M. Long-distance retrograde effects of botulinum neurotoxin A. J. Neurosci. 2008, 28, 3689-3696.
54. Matak, I.; Bach-Rojecky, L.; Filipović, B.; Lacković, Z. Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A. Neuroscience 2011, 186, 201-207.
55. Hughes, R.; Whaler, BC. Influence of nerve-ending activity and of drugs on the rate of paralysis of rat diaphragm preparations by Cl. botulinum type A toxin. J. Physiol. 1962, 160, 221-233.
56. Simpson, L.L. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J. Pharmacol. Exp. Ther. 1980, 212, 16-21.
57. Hanson, M. Use of chemodenervation in dystonic conditions. Cleve. Clin. J. Med. 2012, 79, S25-S29.
58. Geeta, M.G.; Krishnakumar, P.; Mathews, L. Intrathecal tetanus immunoglobulins in the management of tetanus. Indian J. Pediatr. 2007, 74, 43-45.
59. Chukwubike, O.A.; God'spower, A.E. A 10-year review of outcome of management of tetanus in adults at a Nigerian tertiary hospital. Ann. Afr. Med. 2009, 8, 168-172.
60. Azher, S.N.; Jankovic, J. Camptocormia: Pathogenesis, classification, and response to therapy. Neurology 2005, 65, 355-359.
61. Lim, E.C.; Seet, R.C. Botulinum toxin injections to treat belly dancer's dyskinesia. Mov. Disord. 2009, 24, 1401.
62. Jabbari, B. Evidence based medicine in the use of botulinum toxin for back pain. J. Neural. Transm. 2008, 115, 637-640.
63. Marik, P.E. Propofol: Therapeutic indications and side-effects. Curr. Pharm. Des. 2004, 10, 3639-3649.
64. Blitzer, A. Botulinum toxin A and B: A comparative dosing study for spasmodic dysphonia. Otolaryngol. Head Neck Surg. 2005, 133, 836-838.